The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global stem cell banking market was valued at US$ 6.8 Billion in 2021.
We expect the global stem cell banking market to exhibit a CAGR of 8.42% during 2022-2027.
The increasing consumer awareness towards numerous therapeutic benefits of stem cells for treating
several diseases, including diabetes, leukemia, cardiac ailments, etc., is currently driving the global stem
cell banking market.
The sudden outbreak of the COVID-19 pandemic has led to the increasing application of next-generation
stem cell therapy for managing severe symptoms of the coronavirus infection.
Based on the product type, the global stem cell banking market can be segmented into adult stem cells,
human embryonic cells, and IPS cells. Currently, adult stem cells hold the majority of the total market
Based on the service type, the global stem cell banking market has been divided into sample
preservation and storage, sample analysis, sample processing, and sample collection and transportation.
Among these, sample preservation and storage currently exhibits a clear dominance in the market.
Based on the bank type, the global stem cell banking market can be categorized into private and public.
Currently, private stem cell banks account for the majority of the global market share.
Based on the utilization, the global stem cell banking market has been segregated into used and unused,
where unused currently holds the largest market share.
Based on the application, the global stem cell banking market can be bifurcated into personalized
banking applications, research applications, and clinical applications. Among these, clinical applications
currently exhibit a clear dominance in the market.
On a regional level, the market has been classified into North America, Europe, Asia Pacific, Middle East
and Africa, and Latin America, where North America currently dominates the global market.
Some of the major players in the global stem cell banking market include CBR Systems Inc., China Cord
Blood Corporation, Cordlife, Cordvida, Cryo-Cell International, Inc., Cryo-Save AG (A Group of Esperite),
Cryoviva India, Lifecell, Smart Cells International Ltd., Viacord, etc.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at